Black Diamond Therapeutics (BDTX) EBT Growth (3y) (2021 - 2026)
Black Diamond Therapeutics (BDTX) EBT Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 9.34% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 40.43% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 12.01% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -1.05% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 86.16% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Black Diamond Therapeutics | 99.59 Mn | -18.67 Mn | - | 19.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.73% |
| Dec 31, 2025 | 7.55% |
| Sep 30, 2025 | 35.56% |
| Jun 30, 2025 | 24.59% |
| Mar 31, 2025 | 59.79% |
| Dec 31, 2024 | 10.32% |
| Sep 30, 2024 | 16.57% |
| Jun 30, 2024 | 1.15% |
| Mar 31, 2024 | 11.58% |
| Dec 31, 2023 | 1.13% |
| Sep 30, 2023 | -25.44% |
| Jun 30, 2023 | -28.37% |
| Mar 31, 2023 | -20.37% |
| Dec 31, 2022 | -30.92% |
| Sep 30, 2022 | -91.56% |
| Jun 30, 2022 | -62.61% |
| Mar 31, 2022 | -89.29% |
| Dec 31, 2021 | -54.65% |